Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anju Parthan, Gábor Vincze, Donald E Morisky & Zeba M Khan. (2006) Strategies to improve adherence with medications in chronic, ‘silent’ diseases representing high cardiovascular risk. Expert Review of Pharmacoeconomics & Outcomes Research 6:3, pages 325-336.
Read now
Read now
Herbert Schuster & Jonathan C Fox. (2004) Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme™. Expert Opinion on Pharmacotherapy 5:5, pages 1187-1200.
Read now
Read now
Articles from other publishers (15)
Babak Salam, Anne Schrimpf, Sebastian Münster & Markus Bleckwenn. (2023) Statin adherence in patients enrolled in the disease management program for coronary artery disease – comparison between patients’ and general practitioners’ self-reports and patient records. Research in Health Services & Regions 2:1.
Crossref
Crossref
Evgeniya V Shalaeva, Hugo Saner, Bakhtiyor B Janabaev & Aleksandra V Shalaeva. (2017) Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures. European Journal of Preventive Cardiology 24:7, pages 708-716.
Crossref
Crossref
Hildtraud C. Knopf, Markus A. Busch, Yong Du, Julia Truthmann, Anja Schienkiewitz & Christa Scheidt-Nave. (2017) Zeitliche Entwicklung der Anwendungsprävalenz von Statinen in Deutschland – Ergebnisse der nationalen Interview- und Untersuchungssurveys 1997-1999 und 2008-2011. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 122, pages 22-31.
Crossref
Crossref
Pendar Farahani. (2012) A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases. Clinical Diabetes 30:2, pages 54-60.
Crossref
Crossref
Avishay Elis, Michael Lishner & Samuel Melamed. (2011) Treatment beliefs and attending follow-up visits in a lipid clinic. British Journal of Health Psychology 16:1, pages 61-71.
Crossref
Crossref
Richard Kones. (2010) Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Therapeutic Advances in Cardiovascular Disease 5:1, pages 61-81.
Crossref
Crossref
Sandra J. LewisKathleen M. FoxMichael F. BullanoSusan Grandy. (2009) Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia. Circulation: Cardiovascular Quality and Outcomes 2:3, pages 207-212.
Crossref
Crossref
Stefan N. Willich, Heike Englert, Frank Sonntag, Heinz Völler, Wolfgang Meyer-Sabellek, Karl Wegscheider, Eberhard Windier, Hugo Katus & Jacqueline Müller-Nordhorn. (2009) Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin. European Journal of Cardiovascular Prevention & Rehabilitation 16:2, pages 180-187.
Crossref
Crossref
Eric Bruckert, Philippe Giral, François Paillard, Jean Ferrières, Jean-Louis Schlienger, Jean-François Renucci, Kamel Abdennbi, Isabelle Durack & Rita Chadarevian. (2008) Effect of an Educational Program (PEGASE) on Cardiovascular Risk in Hypercholesterolaemic Patients. Cardiovascular Drugs and Therapy 22:6, pages 495-505.
Crossref
Crossref
Joannis E Vamvakopoulos, Melpomeni Kountouri, Tom Marshall & Sheila M Greenfield. (2008) Lifestyle or Life-Saving Medicines? A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins. Annals of Pharmacotherapy 42:3, pages 413-420.
Crossref
Crossref
DEBORAH T. GOLD & SAMANTHA SOLIMEO. 2008. Osteoporosis. Osteoporosis
1547
1553
.
Devin M. Mann & Sundar Natarajan. (2007) Inverse Relationship between Lipid-lowering Drugs and Saturated Fat Intake in US Adults. Cardiovascular Drugs and Therapy 21:2, pages 109-115.
Crossref
Crossref
Y Bezie, M Molina, N Hernandez, R Batista, S Niang & D Huet. (2006) Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes & Metabolism 32:6, pages 611-616.
Crossref
Crossref
John J. LefanteJrJr, Gary N. Harmon, Wendy Roy, Sue Fontenot, Kevin Brown & Larry Webber. (2016) The Effect of Medication Reviews in a Rural Community Pharmacy Assistance Program: The Cenla Medication Access Program. Journal of Pharmacy Practice 18:6, pages 486-492.
Crossref
Crossref
T. Walley, P. Folino-Gallo, P. Stephens & E. Van Ganse. (2005) Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. British Journal of Clinical Pharmacology 60:5, pages 543-551.
Crossref
Crossref